•
Sep 30, 2013

Edwards Lifesciences Q3 2013 Earnings Report

Total Revenue
$496M
Previous year: $448M
+10.7%
EPS
$0.11
Previous year: $0.1
+10.0%
Gross Profit
$366M
Previous year: $336M
+8.8%
Cash and Equivalents
$471M
Previous year: $306M
+54.0%
Total Assets
$2.53B
Previous year: $2.2B
+15.2%

Edwards Lifesciences

Edwards Lifesciences